BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19217505)

  • 41. Oncology nurses' perceptions of obstacles and supportive behaviors at the end of life.
    Beckstrand RL; Moore J; Callister L; Bond AE
    Oncol Nurs Forum; 2009 Jul; 36(4):446-53. PubMed ID: 19581235
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gastric malignancies in breast cancer survivors: pathology and outcomes.
    Ellis MC; Mason T; Barnett J; Kiesow LL; Vetto JT
    Am J Surg; 2009 May; 197(5):633-6. PubMed ID: 19306975
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidemiology of GIST.
    Blanke C; Eisenberg BL; Heinrich M
    Am J Gastroenterol; 2005 Oct; 100(10):2366. PubMed ID: 16181397
    [No Abstract]   [Full Text] [Related]  

  • 44. Diplopia as the first symptom of an aggressive metastatic rectal stromal tumor.
    Barrière J; Thariat J; Vandenbos F; Bondiau PY; Peyrottes I; Peyrade F
    Onkologie; 2009 Jun; 32(6):345-7. PubMed ID: 19521122
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plexiform fibromyxoma: a distinctive benign gastric antral neoplasm not to be confused with a myxoid GIST.
    Miettinen M; Makhlouf HR; Sobin LH; Lasota J
    Am J Surg Pathol; 2009 Nov; 33(11):1624-32. PubMed ID: 19675452
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuroendocrine tumors of the pancreas.
    Ehehalt F; Saeger HD; Schmidt CM; Grützmann R
    Oncologist; 2009 May; 14(5):456-67. PubMed ID: 19411317
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The role of the pathologist in the management of gastrointestinal stromal tumors (GIST)].
    Bouzourene H
    Rev Med Suisse; 2009 Jul; 5(211):1505-8. PubMed ID: 19694360
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current concepts in the diagnosis and management of type 1 gastric neuroendocrine neoplasms.
    Kaltsas G; Grozinsky-Glasberg S; Alexandraki KI; Thomas D; Tsolakis AV; Gross D; Grossman AB
    Clin Endocrinol (Oxf); 2014 Aug; 81(2):157-68. PubMed ID: 24750249
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment of gastrointestinal stromal tumors. The Danish Society for Gastroenterology].
    Mortensen MB;
    Ugeskr Laeger; 2007 Mar; 169(12):1103. PubMed ID: 17394814
    [No Abstract]   [Full Text] [Related]  

  • 50. Presentation, treatment, and analysis of prognostic factors of terminally ill patients with gastrointestinal tumors.
    Gencer D; Kästle-Larralde N; Pilz LR; Weiss A; Buchheidt D; Hochhaus A; Hofheinz RD
    Onkologie; 2009 Jul; 32(7):380-6. PubMed ID: 19556814
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Involvement of focal adhesion kinase in the progression and prognosis of gastrointestinal stromal tumors.
    Kamo N; Naomoto Y; Shirakawa Y; Yamatsuji T; Hirota S; Fujiwara Y; Noma K; Sakurama K; Takaoka M; Nagatsuka H; Gunduz M; Matsuoka J; Tanaka N
    Hum Pathol; 2009 Nov; 40(11):1643-9. PubMed ID: 19695682
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors.
    Kobayashi K; Szklaruk J; Trent JC; Ensor J; Ahrar K; Wallace MJ; Madoff DC; Murthy R; Hicks ME; Gupta S
    Am J Clin Oncol; 2009 Dec; 32(6):574-81. PubMed ID: 19636238
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gastrointestinal stromal tumors presenting as a prostatic mass.
    de la Roza G; Naqvi A; Clark K
    Can J Urol; 2009 Feb; 16(1):4502-6. PubMed ID: 19222892
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Laparoscopic total gastrectomy for multifocal gastric GIST: a case report and review of the literature].
    Siani LM; Ferranti F; Stefanuto A; Benedetti M; Quintiliani A
    Chir Ital; 2009; 61(2):199-203. PubMed ID: 19536994
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiovascular effects of tyrosine kinase inhibitors used for gastrointestinal stromal tumors.
    Chintalgattu V; Patel SS; Khakoo AY
    Hematol Oncol Clin North Am; 2009 Feb; 23(1):97-107, viii-ix. PubMed ID: 19248973
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic factors for primary GIST: prime time for personalized therapy?
    Raut CP; DeMatteo RP
    Ann Surg Oncol; 2008 Jan; 15(1):4-6. PubMed ID: 17932720
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical practice guidelines for patients with gastrointestinal stromal tumor in Taiwan.
    Yeh CN; Hwang TL; Huang CS; Lee PH; Wu CW; Chen-Guo K; Jan YY; Chen MF;
    World J Surg Oncol; 2012 Nov; 10():246. PubMed ID: 23153013
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Gastrointestinal stromal tumors (GISTs). Personal experience on three cases of the tumors of the small intestine complicated and emergency surgically treated].
    Licursi M; Bonsignore A; Fiumara F; Soliera M; Grillone G; Faro G; Pirrone G; Angiò LG
    G Chir; 2009; 30(6-7):276-85. PubMed ID: 19580708
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Carcinoid tumors.
    Pasieka JL
    Surg Clin North Am; 2009 Oct; 89(5):1123-37. PubMed ID: 19836488
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Survival and prognostic factors analysis in surgically resected gastrointestinal stromal tumor patients.
    Song Z; Wang JL; Pan YL; Tao DY; Gan MF; Huang KE
    Hepatogastroenterology; 2009; 56(89):149-53. PubMed ID: 19453047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.